Abstract 15389: Effect of Icosapent Ethyl on Changes in Coronary Plaque Characteristics at 9 Months in Patients With Elevated Triglycerides on Statin Therapy: Insights From EVAPORATE

MLA

Matthew J. Budoff, et al. “Abstract 15389: Effect of Icosapent Ethyl on Changes in Coronary Plaque Characteristics at 9 Months in Patients With Elevated Triglycerides on Statin Therapy: Insights From EVAPORATE.” Circulation, vol. 142, Nov. 2020. EBSCOhost, https://doi.org/10.1161/circ.142.suppl_3.15389.

APA

Matthew J. Budoff, Suvasini Lakshmanan, John R Nelson, April Kinninger, John A. Tayek, Heidi T May, Joseph B. Muhlestein, Kashif Shaikh, Viet T Le, Chandana Shekar, Deepak L. Bhatt, Ilana Golub, Sion K. Roy, & Andrew J. Buckler. (2020). Abstract 15389: Effect of Icosapent Ethyl on Changes in Coronary Plaque Characteristics at 9 Months in Patients With Elevated Triglycerides on Statin Therapy: Insights From EVAPORATE. Circulation, 142. https://doi.org/10.1161/circ.142.suppl_3.15389

Chicago

Matthew J. Budoff, Suvasini Lakshmanan, John R Nelson, April Kinninger, John A. Tayek, Heidi T May, Joseph B. Muhlestein, et al. 2020. “Abstract 15389: Effect of Icosapent Ethyl on Changes in Coronary Plaque Characteristics at 9 Months in Patients With Elevated Triglycerides on Statin Therapy: Insights From EVAPORATE.” Circulation 142 (November). doi:10.1161/circ.142.suppl_3.15389.